Travere Therapeutics TVTX reported its Q3 earnings results on Thursday, October 27, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Travere Therapeutics beat estimated earnings by 14.61%, reporting an EPS of $-0.76 versus an estimate of $-0.89.
Revenue was down $14.72 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.23 which was followed by a 7.91% increase in the share price the next day.
Here's a look at Travere Therapeutics's past performance:
Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
---|---|---|---|---|
EPS Estimate | -0.88 | -0.85 | -0.72 | -0.54 |
EPS Actual | -0.65 | -0.82 | -0.61 | -0.13 |
Revenue Estimate | 49.63M | 51.92M | 57.81M | 60.93M |
Revenue Actual | 54.17M | 48.49M | 57.25M | 68.22M |
To track all earnings releases for Travere Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.